GS

Gobind Singh HC Wainwright & Co. Latest Price Targets & Analyst Ratings

Stock Price Price Target Upside
Downside
Rating Date
OKUR
1
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$35.2M
$2.60 $300
11,438%
upside
Buy 8 Sep ‘23
2 years ago
ANAB icon
2
AnaptysBio
ANAB
$629M
$22.49 $35
56%
upside
Buy 19 Sep ‘22
3 years ago
IMUX icon
3
Immunic
IMUX
$81.3M
$0.8240 $26
3,055%
upside
Buy 19 Sep ‘22
3 years ago
PRTA icon
4
Prothena Corp
PRTA
$461M
$8.56 $77
800%
upside
Market Outperform 19 Nov ‘21
3 years ago
PTGX icon
5
Protagonist Therapeutics
PTGX
$3.46B
$55.58 $70
26%
upside
Market Outperform 15 Nov ‘21
3 years ago
IMUX icon
6
Immunic
IMUX
$81.3M
$0.8240 $55
6,575%
upside
Market Outperform 24 Mar ‘21
4 years ago